PLDT Inc. Sponsored ADR (PHI)

Retained Earnings

₱43.80B

Quarterly · Period ending: · PHP

PHI logo

PHI Retained Earnings

Latest reported₱43.80B PHP
PHI Quarterly Retained Earnings · PHP (₱21.92B → ₱43.80B)
High-resolution chart · PNG

PHI retained earnings history

Quarterly · PHP. Dates are reporting period ends; fiscal years can differ from calendar years.

PLDT Inc. Sponsored ADR Retained Earnings — Quarterly (PHP)
Period endingRetained Earnings (PHP)
43,796,000,000
42,244,000,000
43,185,488,000
38,402,000,000
41,854,000,000
32,757,000,000
33,901,000,000
29,304,000,000
30,465,000,000
21,891,000,000
22,020,000,000
23,300,000,000
24,473,000,000
15,052,000,000
18,799,000,000
36,218,000,000
41,797,000,000
34,149,000,000
34,243,000,000
26,738,000,000
29,902,000,000
22,798,000,000
25,652,000,000
21,070,000,000
21,887,000,000
15,534,000,000
18,063,000,000
10,820,000,000
15,026,000,000
9,684,000,000
12,081,000,000
9,907,000,000
13,215,000,000
8,416,000,000
634,000,000
9,214,000,000
14,299,000,000
2,370,000,000
3,483,000,000
-643,000,000
6,556,000,000
82,000,000
6,195,000,000
9,484,000,000
16,933,000,000
7,606,000,000
17,030,000,000
10,910,000,000
17,899,000,000
7,270,000,000
22,968,000,000
16,516,000,000
20,894,000,000
10,381,000,000
24,794,000,000
17,963,000,000
21,727,000,000
12,317,000,000
26,232,000,000
25,375,000,000
30,956,000,000
20,403,000,000
36,594,000,000
28,445,000,000
33,040,000,000
22,795,000,000
37,744,000,000
28,059,000,000
32,479,000,000
22,352,000,000
37,232,277,600
28,740,251,200
35,414,517,480
26,486,485,480
39,834,881,550
30,404,009,070
40,109,602,260
31,793,528,520
12,454,212,750
23,573,573,550
22,845,607,600
16,109,235,450
-5,250,040,290
7,731,959,220
-112,044,820
-3,561,643,800
-10,224,719,960
24,943,822,320
50,140,056,950
43,988,767,740
-58,055,560,200
38,184,014,501
34,698,024,096
35,847,008,143
-59,224,015,315
37,551,602,251
36,669,216,411
35,415,849,282
34,635,308,100
33,970,795,760
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.